‘Fast but not so Furious’: Short observation time after subcutaneous Daratumumab administration is both a safe and cost-effective strategy

Autor: Davis, James A., Youngberg, Heather, Gaffney, Kelly, Duco, Marissa, Hashmi, Hamza
Zdroj: In Clinical Lymphoma, Myeloma and Leukemia August 2022 22(8):e680-e684
Databáze: ScienceDirect